Literature DB >> 8746637

Assessment of blood pressure measurement quality in the baseline surveys of the WHO MONICA project.

H W Hense1, A M Koivisto, K Kuulasmaa, A Zaborskis, W Kupsc, J Tuomilehto.   

Abstract

Because of the general inavailability of reference standards, there exist no common procedures to assess the quality of blood pressure measurements in epidemiological population surveys. To approach this problem within the collaborative international WHO MONICA Project, a standardized assessment of BP measurement quality was developed and applied to the forty-seven baseline surveys of that project. The entire assessments were carried out in retrospect, that is, only after each population survey had been completed. The assessment was focused on the procedures of quality assurance and control as reportedly applied in each survey, and on quality indicators which were derived from the recorded blood pressure values of each survey. The definitions of specific quality assessment items were based on the MONICA project protocol and on sources in the pertinent literature. The available information on quality assurance and control procedures depended solely on self-reports by local survey organizers and on site visits, and was occasionally found to be at variance with the actual blood pressure recordings. Therefore, quality indicators derived from actual blood pressure recordings were far more informative and comparable between surveys. Each survey was rated as optimal, satisfactory, or unsatisfactory with regard to single quality items and these single scores were used jointly to compute a summary score of blood pressure measurement quality for each survey. This summary score indicated that 39 out of 47 MONICA baseline surveys showed optimal or satisfactory BP measurement quality. Limitations and potentials for improvement of quality assessments became apparent. We conclude that a standardized assessment of BP measurement quality in epidemiological population surveys seems feasible and propose that quality assessment methods similar to the ones suggested here become a routine part of future epidemiological analyses of blood pressure values and hypertension in populations. This should facilitate valid study comparisons.

Entities:  

Mesh:

Year:  1995        PMID: 8746637

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  12 in total

1.  Survey of white coat hypertension. Definition differs from others.

Authors:  K Kario; T G Pickering
Journal:  BMJ       Date:  1999-02-20

2.  Effects of air pollution on blood pressure: a population-based approach.

Authors:  A Ibald-Mulli; J Stieber; H E Wichmann; W Koenig; A Peters
Journal:  Am J Public Health       Date:  2001-04       Impact factor: 9.308

3.  Lipid profile and its association with risk factors for coronary heart disease in the highlanders of Lhasa, Tibet.

Authors:  Lhamo Y Sherpa; Hein Stigum; Virasakdi Chongsuvivatwong; Ouzhu Luobu; Dag S Thelle; Per Nafstad; Espen Bjertness
Journal:  High Alt Med Biol       Date:  2011       Impact factor: 1.981

4.  Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995.

Authors:  H K Wolf; P Andreou; I R Bata; D G Comeau; R D Gregor; G Kephart; D R MacLean; I Sketris
Journal:  CMAJ       Date:  1999-09-21       Impact factor: 8.262

5.  Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey.

Authors:  M W Muscholl; H W Hense; U Bröckel; A Döring; G A Riegger; H Schunkert
Journal:  BMJ       Date:  1998-08-29

6.  Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels.

Authors:  F L Fernandes-Rosa; A C Bueno; R Molina de Souza; M de Castro; J Ernesto dos Santos; M C Foss; M-C Zennaro; H Bettiol; M A Barbieri; S R Antonini
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

7.  Challenges in standardization of blood pressure measurement at the population level.

Authors:  Hanna Tolonen; Päivikki Koponen; Androniki Naska; Satu Männistö; Grazyna Broda; Tarja Palosaari; Kari Kuulasmaa
Journal:  BMC Med Res Methodol       Date:  2015-04-10       Impact factor: 4.615

8.  Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.

Authors:  Klaus Stark; Wibke Reinhard; Katharina Neureuther; Silke Wiedmann; Kamil Sedlacek; Andrea Baessler; Marcus Fischer; Stefan Weber; Bernhard Kaess; Jeanette Erdmann; Heribert Schunkert; Christian Hengstenberg
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

9.  Contextual socioeconomic determinants of cardiovascular risk factors in rural south-west China: a multilevel analysis.

Authors:  Cai Le; Virasakdi Chongsuvivatwong; Alan Geater
Journal:  BMC Public Health       Date:  2007-05-05       Impact factor: 3.295

10.  Arterial blood pressure and long-term exposure to traffic-related air pollution: an analysis in the European Study of Cohorts for Air Pollution Effects (ESCAPE).

Authors:  Kateryna B Fuks; Gudrun Weinmayr; Maria Foraster; Julia Dratva; Regina Hampel; Danny Houthuijs; Bente Oftedal; Anna Oudin; Sviatlana Panasevich; Johanna Penell; Johan N Sommar; Mette Sørensen; Pekka Tiittanen; Kathrin Wolf; Wei W Xun; Inmaculada Aguilera; Xavier Basagaña; Rob Beelen; Michiel L Bots; Bert Brunekreef; H Bas Bueno-de-Mesquita; Barbara Caracciolo; Marta Cirach; Ulf de Faire; Audrey de Nazelle; Marloes Eeftens; Roberto Elosua; Raimund Erbel; Bertil Forsberg; Laura Fratiglioni; Jean-Michel Gaspoz; Agneta Hilding; Antti Jula; Michal Korek; Ursula Krämer; Nino Künzli; Timo Lanki; Karin Leander; Patrik K E Magnusson; Jaume Marrugat; Mark J Nieuwenhuijsen; Claes-Göran Ostenson; Nancy L Pedersen; Göran Pershagen; Harish C Phuleria; Nicole M Probst-Hensch; Ole Raaschou-Nielsen; Emmanuel Schaffner; Tamara Schikowski; Christian Schindler; Per E Schwarze; Anne J Søgaard; Dorothea Sugiri; Wim J R Swart; Ming-Yi Tsai; Anu W Turunen; Paolo Vineis; Annette Peters; Barbara Hoffmann
Journal:  Environ Health Perspect       Date:  2014-05-16       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.